Preferred Label : ergoloid mesylates;

MeSH definition : A mixture of the mesylates (methane sulfonates) of DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and the alpha- and beta-isomers of DIHYDROERGOCRYPTINE. The substance produces a generalized peripheral vasodilation and a fall in arterial pressure and has been used to treat symptoms of mild to moderate impairment of mental function in the elderly.;

MeSH synonym : co-dergine mesylate; ergoloid mesylate; dihydroergotoxine methanesulfonate; ergotoxin, dihydro-, monomethasulfonate; co-dergocrine mesilate; dihydroergotoxine monomethanesulfonate; co-dergocrine mesylate; co dergocrine mesilate; co dergocrine mesylate; methanesulfonate, dihydroergotoxine; monomethanesulfonate, dihydroergotoxine; co dergine mesylate; dihydroergotoxine mesylate;

MeSH hyponym : redergam; redergin; ergodesit; hydergine; circanol; Redergine;

Registry Number MeSH : 8067-24-1;

Wikipedia link : https://en.wikipedia.org/wiki/Ergoloid mesylate;

Is substance : O;

Details


Main resources

You can consult :

A mixture of the mesylates (methane sulfonates) of DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and the alpha- and beta-isomers of DIHYDROERGOCRYPTINE. The substance produces a generalized peripheral vasodilation and a fall in arterial pressure and has been used to treat symptoms of mild to moderate impairment of mental function in the elderly.

http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-11/capergyl_02-11-2011_avis_ct-11262.pdf
http://www.has-sante.fr/portail/jcms/c_1121565/capergyl
2011
France
French
evaluation of the transparency committee
administration, oral
ergoloid mesylates
nootropic agents
ergoloid mesylates
treatment outcome
cognition disorders
aged
insurance, health, reimbursement

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-11/hydergine_02-11-2011_avis_ct-11270.pdf
http://www.has-sante.fr/portail/jcms/c_1121553/hydergine
2011
France
French
ergoloid mesylates
administration, oral
insurance, health, reimbursement
treatment outcome
ergoloid mesylates
vasodilator agents
nootropic agents
aged
cognition disorders
vision, low
vision disorders
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-4830_capergyl_.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_614738
2007
France
French
ergoloid mesylates
administration, oral
ergoloid mesylates
vasodilator agents
insurance, health, reimbursement
nootropic agents
aged
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-4978_hydergine_.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_619466
2007
France
French
ergoloid mesylates
administration, oral
insurance, health, reimbursement
ergoloid mesylates
nootropic agents
vasodilator agents
evaluation of the transparency committee

---
Nous contacter.
24/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.